A panel of judges selected ‘L. casei 431® Juice’ ahead of the pack in the “Best new functional ingredient concept” category. According to the judges, “L. casei 431 Juice from Chr. Hansen is a well thought out concept, backed with solid scientific claims.”
Positive customer feedback
After proudly accepting the prize Chr. Hansen’s Marie Brenoee, Global Marketing Manager, Probiotic Cultures, said: “I am honored to be receiving this accolade on behalf of Chr. Hansen. It confirms the initial feedback from juice and beverage producers who have enquired about the concept: This is a truly remarkable innovation - the probiotic fruit beverage category’s “proof of concept” because of the probiotic’s ability to survive in fruit beverages throughout the product’s shelf life.”
“I foresee that this award will cause even more interest from the international beverage industry which has been glancing at the sweeping success of probiotic yoghurt. Fruit beverage producers too wish to “add the good life to juice”, as we say. Now they have the opportunity to do so with an award-winning probiotic,” Marie Brenoee said with a smile on her face.
Strong survival and documented health benefits
‘L. casei 431® Juice’ is a probiotic developed to survive in low pH environments such as chilled fruit beverages. ‘L. casei 431® Juice’ contains Lactobacillus paracasei 431®. This probiotic strain has very strong scientific documentation on immune health as well as a long history of use in yoghurt and dietary supplement products. With a survival of 10 weeks or more, thus securing long shelf life for the chilled beverage product, ‘L. casei 431® Juice’ outperforms competitive products in the marketplace. Further, ‘L. casei 431® Juice’can survive in many types of fruit beverage types and has no side effects in the beverage such as unpleasant off-flavor or gas formation.
‘L. casei 431® Juice’ was launched in late 2011 and is available for producers of fruit beverages all over the world.
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2012/13 financial year was EUR 738 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.